| Dr Mark Allen Stradling, DO | |
|
1505 Wigwam Pkwy Ste 100, Henderson, NV 89074-8195 | |
| (702) 896-6043 | |
| (702) 896-9591 |
| Full Name | Dr Mark Allen Stradling |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 18 Years |
| Location | 1505 Wigwam Pkwy Ste 100, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982874509 | NPI | - | NPPES |
| 1982874509 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 1576 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shepherd Eye Center Ltd | 9234125907 | 37 |
News Archive
A drug used to treat rheumatoid arthritis also reduces the damage a stroke inflicts on the brain according to lab research and preliminary findings from a clinical trial of stroke patients. The results open the door for a larger clinical study to refine the drug anakinra's use as an effective therapy for victims of stroke.
By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).
Ceregene, a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease.
Sanofi pasteur, the vaccines division of sanofi-aventis Group, has announced data showing that its new investigational H5N1 pandemic influenza vaccine containing a proprietary adjuvant achieved a high immune response at the lowest dose of H5N1 antigen reported to date.
› Verified 6 days ago
| Entity Name | Shepherd Eye Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487604054 PECOS PAC ID: 9234125907 Enrollment ID: O20040420001820 |
News Archive
A drug used to treat rheumatoid arthritis also reduces the damage a stroke inflicts on the brain according to lab research and preliminary findings from a clinical trial of stroke patients. The results open the door for a larger clinical study to refine the drug anakinra's use as an effective therapy for victims of stroke.
By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).
Ceregene, a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease.
Sanofi pasteur, the vaccines division of sanofi-aventis Group, has announced data showing that its new investigational H5N1 pandemic influenza vaccine containing a proprietary adjuvant achieved a high immune response at the lowest dose of H5N1 antigen reported to date.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Allen Stradling, DO 1505 Wigwam Pkwy Ste 100, Henderson, NV 89074-8195 Ph: (702) 896-6043 | Dr Mark Allen Stradling, DO 1505 Wigwam Pkwy Ste 100, Henderson, NV 89074-8195 Ph: (702) 896-6043 |
News Archive
A drug used to treat rheumatoid arthritis also reduces the damage a stroke inflicts on the brain according to lab research and preliminary findings from a clinical trial of stroke patients. The results open the door for a larger clinical study to refine the drug anakinra's use as an effective therapy for victims of stroke.
By creating a unique system of blood vessels that is engineered to interact with the tissue surrounding an implanted device, the longevity and function of these devices may be better preserved, according to a study led by researchers in the University of Louisville/ Jewish Hospital's Cardiovascular Innovation Institute (CII).
Ceregene, a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease.
Sanofi pasteur, the vaccines division of sanofi-aventis Group, has announced data showing that its new investigational H5N1 pandemic influenza vaccine containing a proprietary adjuvant achieved a high immune response at the lowest dose of H5N1 antigen reported to date.
› Verified 6 days ago
Kurt A Buzard, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2657 Windmill Pkwy Ste 140, Henderson, NV 89074 Phone: 702-738-2015 Fax: 702-454-0484 | |
Dr. Darrick William Neibaur, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1505 Wigwam Pkwy Ste 100, Henderson, NV 89074 Phone: 702-896-6043 Fax: 702-896-9591 | |
Dr. Gregory Shoou-ren Hsu, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 299 N Pecos Rd, Henderson, NV 89074 Phone: 702-450-6000 | |
Dr. Alec Lee Amram, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2749 Sunridge Heights Pkwy, Henderson, NV 89052 Phone: 702-358-0472 Fax: 702-425-9955 | |
Dr. Rajy M Rouweyha, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1505 Wigwam Pkwy Ste 100, Henderson, NV 89074 Phone: 702-896-6043 Fax: 702-896-9591 | |
Libby K Kristal, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2390 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-825-2085 Fax: 702-852-5743 | |
Dr. Douglas Charles Lorenz, D.O. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2598 Windmill Pkwy, Henderson, NV 89074 Phone: 702-896-6043 Fax: 702-896-9591 |